Uncovering the roots of Parkinson's disease, together
A global research initiative
Aligning Science Across Parkinson’s (ASAP) is fostering collaboration and resources to better understand the underlying causes of Parkinson’s disease. With scale, transparency, and open access data sharing, we believe we can accelerate the pace of discovery, and inform the path to a cure.
Since ASAP launched in 2017, we have reflected on our journey and impact on the Parkinson’s disease (PD) community. See how our initiative has allowed us to better understand the roots of PD and support the research community. We also invite you to review our Collaborative Research Network’s impact.
As we wrap up 2024, we are excited to share how we pushed the Parkinson’s disease research field forward. Together, our supported programs worked to funnel new ideas into Parkinson’s disease R&D, facilitate the rapid exchange of ideas, ensure researchers can build upon ASAP-funded work, and establish a diverse pipeline for the next generation of researchers.
GP2 announced the 9th data release on the Terra and the Verily® Workbench platforms in collaboration with AMP® PD. This release includes 17,690 additional genotyped participants.
Latest News
ASAP Collaborative Research Network (CRN) Impact Report
From 2020 to 2024, the ASAP CRN supported 35 multidisciplinary, international teams across 14 countries. See how the CRN has accelerated breakthroughs in PD research through collaboration and open science.
Charting New Waters in Parkinson’s Research: Highlights From the 2025 CRN Collaborative Meeting
ASAP’s 2025 Collaborative Meeting welcomed representatives from our 35 CRN teams to share impactful findings on the PD landscape, promote the cross-fertilization of ideas, and provide opportunities to engage the broader CRN across different levels of training.
Investing in Open Science: Key Considerations for Funders
ASAP program officer, Dana Lewis, PhD, joins Preprints in Motion to discuss our open science preprint that covers costs associated with open science policies from a funder’s perspective.
